Works matching IS 17574676 AND DT 2016 AND VI 8 AND IP 2

Results: 11

Targeting netrin-1/ DCC interaction in diffuse large B-cell and mantle cell lymphomas.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 96, doi. 10.15252/emmm.201505480

By:

Broutier, Laura;
Creveaux, Marion;
Vial, Jonathan;
Tortereau, Antonin;
Delcros, Jean‐Guy;
Chazot, Guillaume;
McCarron, Mark J;
Léon, Sophie;
Pangault, Céline;
Gadot, Nicolas;
Colombe, Amélie;
Boulland, Marie‐Laure;
Blachier, Jonathan;
Marie, Julien C;
Traverse‐Glehen, Alexandra;
Donzé, Olivier;
Chassagne‐Clément, Catherine;
Salles, Gilles;
Tarte, Karin;
Mehlen, Patrick

Publication type:

Article

Concise gene signature for point-of-care classification of tuberculosis.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 86, doi. 10.15252/emmm.201505790

By:

Maertzdorf, Jeroen;
McEwen, Gayle;
Weiner, January;
Tian, Song;
Lader, Eric;
Schriek, Ulrich;
Mayanja‐Kizza, Harriet;
Ota, Martin;
Kenneth, John;
Kaufmann, Stefan HE

Publication type:

Article

Sequential treatment with 5-aza-2′-deoxycytidine and deacetylase inhibitors reactivates HIV-1.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 117, doi. 10.15252/emmm.201505557

By:

Bouchat, Sophie;
Delacourt, Nadège;
Kula, Anna;
Darcis, Gilles;
Van Driessche, Benoit;
Corazza, Francis;
Gatot, Jean‐Stéphane;
Melard, Adeline;
Vanhulle, Caroline;
Kabeya, Kabamba;
Pardons, Marion;
Avettand‐Fenoel, Véronique;
Clumeck, Nathan;
De Wit, Stéphane;
Rohr, Olivier;
Rouzioux, Christine;
Van Lint, Carine

Publication type:

Article

Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 105, doi. 10.15252/emmm.201505456

By:

Testoni, Ewelina;
Stephenson, Natalie L;
Torres‐Ayuso, Pedro;
Marusiak, Anna A;
Trotter, Eleanor W;
Hudson, Andrew;
Hodgkinson, Cassandra L;
Morrow, Christopher J;
Dive, Caroline;
Brognard, John

Publication type:

Article

Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 139, doi. 10.15252/emmm.201505644

By:

Dudek, Jan;
Cheng, I‐Fen;
Chowdhury, Arpita;
Wozny, Katharina;
Balleininger, Martina;
Reinhold, Robert;
Grunau, Silke;
Callegari, Sylvie;
Toischer, Karl;
Wanders, Ronald JA;
Hasenfuß, Gerd;
Brügger, Britta;
Guan, Kaomei;
Rehling, Peter

Publication type:

Article

CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer: a personalized molecular surgical therapy.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 83, doi. 10.15252/emmm.201506006

By:

Tang, Huibin;
Shrager, Joseph B

Publication type:

Article

Pancreatic cancer microenvironment, to target or not to target?

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 80, doi. 10.15252/emmm.201505948

By:

Carr, Ryan M;
Fernandez‐Zapico, Martin E

Publication type:

Article

IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 155, doi. 10.15252/emmm.201505395

By:

Catarinella, Mario;
Monestiroli, Andrea;
Escobar, Giulia;
Fiocchi, Amleto;
Tran, Ngoc Lan;
Aiolfi, Roberto;
Marra, Paolo;
Esposito, Antonio;
Cipriani, Federica;
Aldrighetti, Luca;
Iannacone, Matteo;
Naldini, Luigi;
Guidotti, Luca G;
Sitia, Giovanni

Publication type:

Article

On the road to replication.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 77, doi. 10.15252/emmm.201505965

By:

Diffley, John FX

Publication type:

Article

The awesome lysosome.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 73, doi. 10.15252/emmm.201505966

By:

Ballabio, Andrea

Publication type:

Article

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.

Published in:

EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 171, doi. 10.15252/emmm.201506162

By:

Oh, Sang‐Min;
Chang, Mi‐Yoon;
Song, Jae‐Jin;
Rhee, Yong‐Hee;
Joe, Eun‐Hye;
Lee, Hyun‐Seob;
Yi, Sang‐Hoon;
Lee, Sang‐Hun

Publication type:

Article